Published in J Neurol on September 12, 1977
Multiple sclerosis: treatment and prophylaxis. J R Soc Med (1979) 0.75
Polyunsaturated fatty acids and colchicine in multiple sclerosis. Br Med J (1979) 0.75
Spontaneous and mutagen induced sister chromatid exchange in multiple sclerosis. J Med Genet (1983) 0.75
Lymphocyte sensitisation: an in-vitro test for cancer? Lancet (1970) 8.23
Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia? Br Med J (1971) 5.53
Randomized clinical trial assessing the effect of Doppler-optimized fluid management on outcome after elective colorectal resection. Br J Surg (2006) 3.91
Specific suppression of the antibody response by antibodies to receptors. Proc Natl Acad Sci U S A (1972) 3.02
Circulating sensitised lymphocytes in Graves' disease. Observations on its pathogenesis. Lancet (1970) 2.73
Specific inhibition of plaque formation to phosphorylcholine by antibody against antibody. Science (1972) 2.73
Zika virus infection of the central nervous system of mice. Arch Gesamte Virusforsch (1971) 2.63
[Virus proteins. IV. Constitution of the coat protein of the fd phage]. Hoppe Seylers Z Physiol Chem (1969) 2.56
Lymphocyte sensitization in advanced malignant disease: a study of serum lymphocyte depressive factor. Br J Cancer (1972) 2.46
Cyclosporin A-binding protein (cyclophilin) of Neurospora crassa. One gene codes for both the cytosolic and mitochondrial forms. J Biol Chem (1988) 2.43
Sensitization of blood lymphocytes to possible antigens in neurological disease. Eur Neurol (1970) 2.19
The connexions of the spinal sub-arachnoid space with the lymphatic system. J Anat (1948) 2.18
Specific laboratory test for diagnosis of multiple sclerosis. Br Med J (1974) 2.17
Electron microscopic observations on the cerebellar cortex in kuru. J Neurol Sci (1969) 2.14
Tumour cell dissemination following endoscopic stent insertion. Br J Surg (2007) 2.10
Regulation of immune response by autogenous antibody against receptor. Proc Natl Acad Sci U S A (1974) 2.05
Demonstration of sensitized lymphocytes in blood. J Clin Pathol (1971) 2.04
Incidence and frequency or complications and management of Meckel's diverticulum. Surg Gynecol Obstet (1989) 1.98
Letter: A rational prophylactic therapy for multiple sclerosis? Lancet (1973) 1.97
Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans. Proc Natl Acad Sci U S A (1991) 1.97
The influence of surgical operations on components of the human immune system. Br J Surg (1985) 1.75
Unsaturated fatty acids in multiple sclerosis. Br Med J (1973) 1.75
Specific suppression of immune responses. Science (1973) 1.67
Macroglobulin structure: homology of mu and gamma heavy chains of human immunoglobulins. Science (1969) 1.64
Neonatal tolerance induced by antibody against antigen-specific receptor. Science (1974) 1.61
Platelet stickiness in multiple sclerosis. Lancet (1965) 1.58
CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int (2007) 1.58
The infective process in scrapie. Lancet (1968) 1.56
Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation (2001) 1.54
Transmission experiments with multiple sclerosis: an interim report. Br Med J (1966) 1.51
Node negative breast cancer: the prognostic value of DNA ploidy for long-term survival. Br J Surg (1991) 1.50
Darwin's illness. Lancet (1990) 1.49
Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay. Rheumatology (Oxford) (2008) 1.49
The response to phosphorylcholine: dissecting an immune response. Transplant Rev (1975) 1.49
The macrophage electrophoretic migration (MEM) test for lymphocyte sensitization. A study of the kinetics. Clin Exp Immunol (1973) 1.49
Viruses in multiple sclerosis? Lancet (1972) 1.48
"Spontaneous" lymphocyte reactivity in the presence of virus infection. Lancet (1972) 1.48
Two major groups of neutralizing anti-gp120 antibodies exist in HIV-infected individuals. Evidence for epitope diversity around the CD4 attachment site. J Immunol (1992) 1.47
Lymphocyte transformation in multiple sclerosis. Inhibition of unstimulated thymidine uptake by a serum factor. Lancet (1968) 1.46
Experiences learned in the successful establishment of a nonheart beating donor program for renal transplantation. J Urol (2003) 1.45
An electron-microscopic study of scrapie in the rat: further observations on "inclusion bodies" and virus-like particles. J Neurol Sci (1972) 1.45
Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl (2001) 1.44
Suppression by autogenous complementary idiotypes: the priority of the first response. J Exp Med (1976) 1.43
A human flora-associated rat model of the breast-fed infant gut. J Pediatr Gastroenterol Nutr (2003) 1.43
Three variable-gene pools common to IgM, IgG and IgA immunoglobulins. Nature (1970) 1.41
Invasion of neurones in vitro by non immune lymphocytes. An electron microscopic study. Br J Exp Pathol (1968) 1.41
Administration of ATG according to the absolute T lymphocyte count during therapy for steroid-resistant rejection. Transpl Int (1993) 1.41
Lymphocyte sensitization to basic protein of brain in malignant neoplasia: experiments with serotonin and related compounds. Nature (1971) 1.41
The effect of 3-week tamoxifen treatment on oestrogen receptor levels in primary breast tumours: a flow cytometric study. Br J Cancer (1998) 1.40
Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant (1999) 1.40
Lymphocyte sensitization in sarcoidosis. Br Med J (1971) 1.39
[Quality assurance in bariatric surgery in Germany--results of the German multicentre trial 2005 and 2006]. Zentralbl Chir (2008) 1.38
Lymphocyte trnsformation induced by encephalitogenic factor in multiple sclerosis and other neurological diseases. Lancet (1968) 1.36
Effect of perioperative blood transfusion on recurrence of colorectal cancer. Br J Surg (1986) 1.36
A common tumour specific antigen. I. Restriction in vivo to malignant neoplastic tissue. Br J Cancer (1973) 1.34
PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy. Am J Transplant (2008) 1.34
The aldolase-binding site of the human erythrocyte membrane is at the NH2 terminus of band 3. J Biol Chem (1981) 1.31
Preparation and analysis of seven major, topographically defined fragments of band 3, the predominant transmembrane polypeptide of human erythrocyte membranes. Biochemistry (1978) 1.30
Lymphocyte transformation in the Guillain-Barré syndrome. Lancet (1969) 1.29
[Sterno-costo-clavicular hyperostosis: a hitherto undescribed entity (author's transl)]. Dtsch Med Wochenschr (1975) 1.28
Experimental allergic encephalomyelitis. An electron microscopic study. Am J Pathol (1966) 1.28
Import of cytochrome c into mitochondria. Cytochrome c heme lyase. Eur J Biochem (1987) 1.28
Blood transfusion and tumour growth: evidence from laboratory animals. Lancet (1981) 1.27
Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine. Klin Wochenschr (1982) 1.26
Localization of tumour specific antigen on external surface of plasma membrane. Nat New Biol (1972) 1.25
Clonal restriction of the immune response to phosphorylcholine. Nature (1974) 1.25
Isolation of an "antigen" from malignant tumours. Br J Cancer Suppl (1973) 1.24
Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. Kidney Int (1986) 1.23
Interaction of cimetidine with metoprolol, propranolol, or atenolol. Lancet (1981) 1.22
Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation. Br J Cancer Suppl (1973) 1.21
Anti-receptor antibody. II. Induction of long-term unresponsiveness in neonatal mice. J Immunol (1975) 1.19
Human endothelial cells: effect of TNF-alpha on peripheral blood mononuclear cell adhesion. Immunology (1991) 1.19
Immunosuppression with polyunsaturated fatty acids in renal transplantation. Transplantation (1977) 1.18
T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant (2000) 1.17
Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int (2001) 1.17
Paramyxovirus like tubules in multiple sclerosis biopsy material. Acta Neuropathol (1973) 1.17
Is maternal lymphocyte sensitisation passed to the child? Lancet (1971) 1.16
Effect of prolonged ingestion of gamma-linolenate by MS patients. Eur Neurol (1978) 1.16
Sternocostoclavicular hyperostosis: painful swelling of the sternum, clavicles, and upper ribs. Report of two new cases. Ann Intern Med (1977) 1.16
Biomaterial-induced sarcoma: A novel model to study preneoplastic change. Am J Pathol (2000) 1.15
Slow virus infections of the nervous system. Int Rev Exp Pathol (1969) 1.15
On the mode of action of antilymphocytic serum: experiments on electrophoretic mobility of macrophages in experimental allergic encephalomyelitis. Clin Exp Immunol (1970) 1.15
Macrophage electrophoretic migration (MEM) test for lymphocyte sensitization: some practical experiences in macrophage selection. Br J Cancer Suppl (1973) 1.15
The cloven hoof in legal medicine. Int J Legal Med (2001) 1.15
Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant (1997) 1.15
Erythrocyte-UFA (Eufa) mobility test for multiple sclerosis: implications for pathogenesis and handling of the disease. J Neurol (1977) 1.14
Priapism during regular haemodialysis. Lancet (1974) 1.14
In-vitro inhibition by unsaturated fatty acids of the PPD- and PHA-induced lymphocyte response. Klin Wochenschr (1974) 1.13
Immunodiagnosis of cancer. Br Med J (1972) 1.13
Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int (1995) 1.12
Anti-macrophage component of antilymphocytic serum. Lancet (1969) 1.12
Scrapie in the rat: an electron-microscopic study. II. Glial inclusions. Acta Neuropathol (1967) 1.11
gamma-Linolenate in multiple schlerosis. Lancet (1978) 1.10
Antibodies to measles antigen, control antigen, and monkey kidney antigen. Studies in patients with multiple sclerosis and other neurological diseases and normal healthy individuals. Neurology (1969) 1.10
Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses. J Clin Invest (1987) 1.09
Inhibitory effect of unsaturated fatty acids on lymphocyte-antigen interaction with special reference to multiple sclerosis. Acta Neurol Scand (1975) 1.09